open access

Vol 19, No 4 (2012)
Original articles
Submitted: 2013-01-24
Published online: 2012-07-09
Get Citation

Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction

Sukru Aksoy, Nese Cam, Ufuk Gurkan, Dilaver Oz, Kivilcim Özden, Servet Altay, Gündüz Durmus, Mehmet Agirbasli
DOI: 10.5603/cj.22983
·
Cardiol J 2012;19(4):381-386.

open access

Vol 19, No 4 (2012)
Original articles
Submitted: 2013-01-24
Published online: 2012-07-09

Abstract

Background: Cigarette smoking increases the oxidative stress mediated vascular dysfunction in young adults. We aimed to investigate the relation between the oxidative stress indices and coronary artery disease (CAD) severity in young patients presenting with acute myocardial infarction (AMI).

Methods: Young patients (aged < 35 years) who were admitted consecutively to our hospital with a diagnosis of AMI were included in the study. Age matched healthy subjects were selected as controls. Oxidative stress indices including lipid hydroperoxide (LOOH), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), paraoxonase (PON) and arylesterase (ARE) activities were measured in serum. CAD severity was assessed by calculating the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxusand Cardiac Surgery Study) score. We analyzed the association between the oxidative indices and CAD severity.

Results: Forty two young patients were admitted to the hospital with AMI (age 32.4 ± 2.6 years; 39 males, 3 females). Current and heavy smoking was commonly observed among the patients (79%). All patients underwent emergency coronary angiography. Twenty-eight healthy subjects were selected as controls. Patients had significantly higher OSI and TOS levels (median, interquartile range) [0.44 (0.26–1.75) vs 0.25 (0.22–0.30), p < 0.001 and 6.0 (4.4–20.8) vs 4.1 (3.7–4.6), p < 0.001], respectively, and lower TAS and LOOH levels [1.6 ± 0.1 vs 1.7 ± 0.1, p = 0.02 and 3.0 ± 0.8 vs 3.6 ± 0.4, p= 0.001], respectively, compared to the control group. CAD severity correlated positively with OSI (r = 0.508, p = 0.001) and TOS levels (r = 0.471, p = 0.002). Subjects with an intermediate to high SYNTAX score (≥ 22) demonstrated significantly higher OSI (median, interquartile range) [0.40 (0.34–1.75) vs 0.34 (0.26–0.68), p = 0.01] and TOS [6.9 (4.4–20.8) vs 5.8 (4.5–11.4), p = 0.01] levels compared to subjects with low SYNTAX score.

Conclusions: Oxidative stress is an important contributor to CAD severity among young smokers. Elevated OSI and TOS levels reflect disease severity and vascular damage related to heavy smoking in early onset CAD.

Abstract

Background: Cigarette smoking increases the oxidative stress mediated vascular dysfunction in young adults. We aimed to investigate the relation between the oxidative stress indices and coronary artery disease (CAD) severity in young patients presenting with acute myocardial infarction (AMI).

Methods: Young patients (aged < 35 years) who were admitted consecutively to our hospital with a diagnosis of AMI were included in the study. Age matched healthy subjects were selected as controls. Oxidative stress indices including lipid hydroperoxide (LOOH), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), paraoxonase (PON) and arylesterase (ARE) activities were measured in serum. CAD severity was assessed by calculating the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxusand Cardiac Surgery Study) score. We analyzed the association between the oxidative indices and CAD severity.

Results: Forty two young patients were admitted to the hospital with AMI (age 32.4 ± 2.6 years; 39 males, 3 females). Current and heavy smoking was commonly observed among the patients (79%). All patients underwent emergency coronary angiography. Twenty-eight healthy subjects were selected as controls. Patients had significantly higher OSI and TOS levels (median, interquartile range) [0.44 (0.26–1.75) vs 0.25 (0.22–0.30), p < 0.001 and 6.0 (4.4–20.8) vs 4.1 (3.7–4.6), p < 0.001], respectively, and lower TAS and LOOH levels [1.6 ± 0.1 vs 1.7 ± 0.1, p = 0.02 and 3.0 ± 0.8 vs 3.6 ± 0.4, p= 0.001], respectively, compared to the control group. CAD severity correlated positively with OSI (r = 0.508, p = 0.001) and TOS levels (r = 0.471, p = 0.002). Subjects with an intermediate to high SYNTAX score (≥ 22) demonstrated significantly higher OSI (median, interquartile range) [0.40 (0.34–1.75) vs 0.34 (0.26–0.68), p = 0.01] and TOS [6.9 (4.4–20.8) vs 5.8 (4.5–11.4), p = 0.01] levels compared to subjects with low SYNTAX score.

Conclusions: Oxidative stress is an important contributor to CAD severity among young smokers. Elevated OSI and TOS levels reflect disease severity and vascular damage related to heavy smoking in early onset CAD.

Get Citation

Keywords

young smokers; myocardial infarction; oxidative stress; OSI; TOS

About this article
Title

Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction

Journal

Cardiology Journal

Issue

Vol 19, No 4 (2012)

Pages

381-386

Published online

2012-07-09

Page views

996

Article views/downloads

1620

DOI

10.5603/cj.22983

Bibliographic record

Cardiol J 2012;19(4):381-386.

Keywords

young smokers
myocardial infarction
oxidative stress
OSI
TOS

Authors

Sukru Aksoy
Nese Cam
Ufuk Gurkan
Dilaver Oz
Kivilcim Özden
Servet Altay
Gündüz Durmus
Mehmet Agirbasli

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl